ConductScience.org, home

Gene · 5618

Papers2,965

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Potential association between endocrine disrupting chemicals (EDCs) and gynecomastia: a systematic review based on partial experimental evidenceendocrine-disrupting chemicals.Front Endocrinol (Lausanne)202641710411PubTator, text miningPubMed
Spinal glial cell derived extra-pituitary prolactin contributes to postoperative pain in females.Front Aging Neurosci202641710110PubTator, text miningPubMed
Ovarian Cancer and High Body-Mass Index: A Global Burden of Disease Database Study From 1990 to 2021.Cancer Med202641645557PubTator, text miningPubMed
A neuropeptide receptor-enriched transcriptional state characterizes resilient dopaminergic neurons in Parkinson's disease.Neurobiol Dis202641638368PubTator, text miningPubMed
Regulation of Lipid Biology-Associated Gene Expression in Granulosa Cells in Hyperandrogenic PCOS: A Possible Link Between Dyslipidemia and Hyperandrogenism.Lipids202641605187PubTator, text miningPubMed
Recent advances in bispecific antibody-drug conjugates for breast cancer therapy.Cancer Chemother Pharmacol202641579215PubTator, text miningPubMed
Neighborhood nonnegative matrix factorization identifies patterns and spatially-variable genes in large-scale spatial transcriptomics data.Genome Biol202641546049PubTator, text miningPubMed
Systematic analyses uncover endocrine-disrupting chemical-responsive genes linked to endometriosis.Reprod Toxicol202641443441PubTator, text miningPubMed
Uncovering novel biomarkers and drug targets for androgenetic alopecia via metabolite regulation and multi-tissue validation.Free Radic Biol Med202641285252PubTator, text miningPubMed
Successful management of refractory hyperprolactinemia secondary to ectopic prolactin-secreting disseminated peritoneal leiomyomatosis via surgical resection and postoperative leuprorelin therapy: a rare case report.
Gynecol Pelvic Med202542211934PubTator, text miningPubMed
Research progress on mechanisms and applications of Chinese herbal pairs in treating hyperplasia of mammary gland.Front Pharmacol202541756114PubTator, text miningPubMed
Impact of lactation stage, maternal age, and parity on mammary epithelial cell populations in fresh milk.Sci Rep202541444818PubTator, text miningPubMed
Microbiota-host crosstalk: the role of short-term dietary restriction in neurological and metabolic dysregulation.NPJ Biofilms Microbiomes202541361190PubTator, text miningPubMed
Molecular phylogeny and species delimitation unravel climate-driven diversification and cryptic radiation in Iranian steppe Vipers (Vipera ursinii-renardi complex).Sci Rep202541298632PubTator, text miningPubMed
Prolactin and DNA damage trigger an anti-breast cancer cell immune response.Front Endocrinol (Lausanne)202541064357PubTator, text miningPubMed
Identification and 3D modeling of bioactive peptides from Lactobacillus brevis RAMULAB49 protein hydrolysate with in silico ERK1 phosphorylation inhibition activity targeting diabetic nephropathy.PLoS One202540982457PubTator, text miningPubMed
Osthole suppresses prostate cancer progression by modulating PRLR and the JAK2/STAT3 signaling axis.Front Oncol202540978029PubTator, text miningPubMed
Idiopathic hyperprolactinemia-associated hypogonadism in men presenting with normal testosterone levels.PLoS One202540966237PubTator, text miningPubMed
B lymphoproliferative diseases: Effective treatment, inhibited progression, and potential cures through isoform-specific targeting of the prolactin receptor.Vitam Horm202540812948PubTator, text miningPubMed
Single-cell RNA sequencing identifies the prolactin receptor as a therapeutic target in adenomyosis.Signal Transduct Target Ther202540804233PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/5618/papers?page=2